Chronic viral hepatitis in patients with ultrasound-guided percutaneous cutting needle liver biopsy evaluation

Abstract

Objective: Liver needle biopsy in determining the properties of diffuse hepatic disease stage and grade is reported to be the most effective method. In patients with chronic viral hepatitis B and C determination of the stage and grade, determination of appropriate treatment in these patients and management is required to decide the prognosis. Method: Between January 2008 and September 2013 ultrasound-guided liver biopsy of the 120 patients with chronic viral hepatitis B and C were evaluated retrospectively. Results: : Liver biopsy in 120 patients women: 45 37.5% , male: 75 62.5% , mean age: 40.8 ± 15.0 years . Average size of pieces was 1.48 ± 0.39 mm from the 120 biopsies have taken. 111 92.5% were diagnostic, two 1.7% patients was recommended biopsy repetition. 7 5.8% patients were assessed as inadequate. Major complication was observed in one of 120 patients 0.83% , minor complication was observed in 9 7.5% patients. Conclusion: According to our experience in our clinical, ultrasound-guided percutaneous liver biopsy using automated biopsy needle fast, effective, minimally invasive and safe method. The complication rate is very low. We consider liver biopsies in all cases should be performed with ultrasound guidance.

Keywords

• Ultrasound Guided Biopsy, chronic viral hepatitis, Cutting Needle

Kronik Viral Hepatitli Hastalarda Ultrasonografi Eşliğinde Kesici İğne İle Yapılan Perkutan Karaciğer Biyopsilerinin Değerlendirilmesi

Abstract

Amaç: Karaciğer iğne biyopsisi diffüz hepatik hastalıkların stage ve grade özelliklerinin belirlenmesinde en etkin yöntem olarak bildirilmektedir. Kronik viral hepatit B ve C hastalarında stage ve grade'in belirlenmesi; bu hastalarda uygun tedavinin belirlenmesi, yönetimi prognozun belirlenmesinde gereklidir. Yöntem: Ocak 2008-Eylul 2013 tarihleri arasında kronik viral hepatit B ve C hastalarında ultrason eşliğinde uygulanan 120 karaciğer biyopsisi retrospektif olarak değerlendirildi. Bulgular: Karaciğer biyopsisi yapılan 120 hastanın kadın: 45 37,5 % , erkek: 75 62,5 % ; ortalama yaş: 40,8±15,0 yıl . 120 biyopside alınan parçaların ortalama boyutları 1,48±0,39 mm olarak bulundu. Biyopsilerin 111 i %92,5 tanısaldı. 2 %1,7 hastada biyopsi tekrarı önerildi, 7 hastada biyopsi materyali yetersiz olarak değerlendirildi. 120 hastadan 1 %0,83 tanesinde major komplikasyon, 9 %7,5 tanesinde minor komplikasyon izlendi. Sonuç: klinik tecrübemize göre, ultrasonografi eşliğinde otomatik biyopsi iğnesi kullanılarak yapılan perkutan karaciğer biyopsisi hızlı, etkili, minimal inviziv ve güvenli bir yöntemdir. Komplikasyon oranı çok düşüktür. Tüm olgularda karaciğer biyopsisinin ultrasonografi kılavuzluğunda yapılması gerekliliğini düşünüyoruz.

Keywords

• Ultrasonografi Kılavuzluğunda Biyopsi, Kronik viral hepatit, Kesici İğne

References

1. 1. Mauldin J, Cameron HD, Jeanotte D, Solomon G, Jarvis JN. Chronic arthritis in children and adolescents in two Indian health service user populations. BMC Musculoskeletal Disorders 2004;5:1-7.
2. 2. Davies K, Copeman A. The spectrum of paediatric and adolescent rheumatology. Best Pract Res Clin Rheumatol 2006;20:179-200.
3. 3-Siegel DM. Chronic arthritis in adolescence. Adolesc Med State Art Rev. 2007;18:47-61.
4. 4. Guillaume S. Juvenile oligoarthritis. A diagnosis not to be ignored. Presse Med 2000;29:517-20.
5. 5. Gülle S, Açarı C, Serdaroğlu E, Can D, Bak M. Çocukluk Çağı Artritinde Etiyoloji. 50.Milli Pediatri Kongresi, 8-12 Kasım 2006, Antalya, Bildiri Özet Kitabı, PP-399.
6. 6. Petty RE, Cassidy JT. Introduction to the study of rheumatic diseases in children, In: Cassidy J. T, Petty R. E (Eds): Textbook of Pediatric Rheumatology. 4th ed. W.B. Saunders, Philadelphia 2001:5-10.
7. 7. Gülle S, Bak M, Açar C, Can D, Serdaroğlu E. Artrit Tanısıyla Yatan Hastaların Etiyolojik Sınıflandırılması. Ege Pediatri Bülteni 2008, 15:7-13.
8. 8. Ryan MJ, Kavanagh P, Wall G, Hazleman BL. Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol. 1997, 36: 370-3.

9. 9. Knights EM. Infectious arthritis. J Foot Surg 1982; 21: 229-4.
10. 10. Barton LL, Dunkle L M, Habib FH. Septic arthritis in childhood. A 13-year review. Am J Dis Child 1987;141: 898-2.
11. 11. Boros C, Whitehead B. Juvenile idiopathic Arthritis. Reprinted from Austra Lian Family Physician 2010;39:9.
12. 12. Miller M. L, Petty RE. Rhematic Disease of Childhood (Connective Tissue Discase, Collogen Vascular Diseases), In: Kliegman R. M, Behrman R. E, Jenson H. B, Stanton B. F (Eds): Nelson Textbook of Pediatrics.18th ed. Saunders, Philadelphia 2007. p. 995- 1051.
13. 13. Azouz EM, Duffy CM. Juvenile spondyloarthropathies: clinical manifestations and medical imaging. Skeletal Radiol 1995;24:399-408.
14. 14. Job-Deslandre C. Juvenile spondylarthropathy. Presse Med 2000;29:510-6.
15. 15. Prieur AM. Spondyloarthropathies in childhood. Baillieres Clin Rheumatol 1998;12:287-307.
16. 16. Stoll ML, Bhore R, Dempsey-Robertson M, Punaro M. Spondyloarthritis in a pediatric population: risk factors for sacroiliitis. J Rheumatol. 2010;37:2402-8.
17. 17. Gerber MA, Zemel LS, Shapiro ED. Lyme arthritis in children: clinical epidemiology and long-term outcomes. Pediatrics. 1998;102:905-8.
18. 18. Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. Engl J Med. 1996;335:1270-4.
19. 19. Al-Eissa YA, Kambal AM, Alrabeeah AA, Abdullah AM, al-Jurayyan NA, al-Jishi NM. Osteoarticular brucellosis in children. Ann Rheum Dis. 1990;49:896-900.
20. 20. Hashemi SH, Keramat F, Ranjbar M, Mamani M, Farzam A, Jamal-Omidi S. Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran. Int J Infect Dis. 2007;11:496-500.
21. 21. Lennon D. Acute rheumatic fever in children: recognition and treatment. Paediatr Drugs. 2004;6:363-73.
22. 22. Cerniauskiene V, Jakutovic M, Panaviene V. Poststreptococcal reactive arthritis. Medicina 2004;40:414-8.
23. 23. Majeed HA, Rawashdeh M. The clinical patterns of arthritis in children with familial Mediterranean fever. QJM. 1997;90:37-43.
24. 24. Reed AM, Lopez M. Juvenile dermatomyositis: recognition and treatment. Paediatr Drugs. 2002;4:315-21.
25. 25. Dressler F, Huppertz HI. Juvenile dermatomyositis. Z Rheumatol. 2006;65:587-90.
26. 26. Quain RD, Werth VP. Management of cutaneous dermatomyositis: current therapeutic options. Am J Clin Dermatol. 2006;7:341-51.
27. 27. Uziel Y, Hashkes PJ. Growing pains in children. Harefuah. 2008;147:809-11.
28. 28. Manners P. Are growing pains a myth? Aust Fam Physician. 1999;28:124-7.
29. 29. Asadi-Pooya AA, Bordbar MR. Are laboratory tests necessary in making the diagnosis of limb pains typical for growing pains in children? Pediatr Int. 2007;49:833-5.
30. 30. Hashkes PJ, Wright BM, Lauer MS, Worley SE, Tang AS, Roettcher PA, Bowyer SL. Mortality outcomes in pediatric rheumatology in the US. Arthritis Rheum. 2010;62:599-608
31. 31. Ringold S, Wallace CA, Rivara FP. Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis. J Rheumatol. 2009;36:1330-6.
32. 32. Cassidy JT. Rheumatic Diseases of Childhood. In: McMillan JA, Feigen RD, DeAngelis CD, Jones MD (Eds): Oski’s Pediatrics. 4th ed. Philadelphia: Lippincott Williams-Wilkins; 2006, 2537-25.sss